Dawnsail Biotech was founded in 2013. In 2014, Dawnsail pioneered the world's first quantitative Fluorescent LAteral flow test Strip for animal Health (qFLASH) to detect canine parvovirus. In 2017, we received investment from a vet veture capital. In 2019, Dawnsail began to develop microFluidic Isothermal amplification Nucleic acid Detection (mFIND) chips for detecting pathogens. In 2024, Dawnsail became the first in the world to launch a mFIND chip for detecting pathogenic nucleic acids in just 15 minutes. That same year, Dawnsail's production factory obtained immunological class B GMP certification from the Ministry of Agriculture. Currently, Dawnsail serves over 10,000 domestic pet clinics and nearly 1,000 pet clinics overseas.

The founder of Dawnsail got a bachelor degree from Nankai University and a Ph.D. in Molecular Biology from the Institute of Biophysics, Chinese Academy of Sciences. He then completed postdoctoral research in Molecular Virology at Brigham and Women's Hospital, Harvard Medical School. He also led the development of diagnostic reagent for human diseases at Abbott and PerkinElmer for around 5 years. In 2014, he received official certificate of leading entrepreneurial talent in Jiaxing.